Your browser doesn't support javascript.
loading
A phase II trial of GSK2256098 and trametinib in patients with advanced pancreatic ductal adenocarcinoma.
Aung, Kyaw L; McWhirter, Elaine; Welch, Stephen; Wang, Lisa; Lovell, Sophia; Stayner, Lee-Anne; Ali, Saara; Malpage, Anne; Makepeace, Barbara; Ramachandran, Makilpriya; Jang, Gun Ho; Gallinger, Steven; Zhang, Tong; Stockley, Tracy L; Fischer, Sandra E; Dhani, Neesha; Hedley, David; Knox, Jennifer J; Siu, Lillian L; Goodwin, Rachel; Bedard, Philippe L.
Afiliação
  • Aung KL; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • McWhirter E; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Welch S; Juravanski Cancer Centre, Hamilton, ON, Canada.
  • Wang L; London Health Science Centre, London, ON, Canada.
  • Lovell S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Stayner LA; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Ali S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Malpage A; Ottawa Hospital Cancer Centre, Ottawa, ON, Canada.
  • Makepeace B; London Health Science Centre, London, ON, Canada.
  • Ramachandran M; Juravanski Cancer Centre, Hamilton, ON, Canada.
  • Jang GH; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Gallinger S; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Zhang T; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Stockley TL; Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Fischer SE; Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Dhani N; Divison of Laboratory Genetics, Laboratory Medicine Program, Department of Pathology, University Health Network, Toronto, ON, Canada.
  • Hedley D; Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, ON, Canada.
  • Knox JJ; Department of Pathology, University Health Network, Toronto, ON, Canada.
  • Siu LL; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Goodwin R; Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Bedard PL; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
J Gastrointest Oncol ; 13(6): 3216-3226, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36636049

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article